The use of vismodegib to shrink keratocystic odontogenic tumors in basal cell nevus syndrome patients

Por Ally, Mina S., Tang, Jean Y., Joseph, Timmy, Thompson, Bobbye, Lindgren, Joselyn, Raphael, Maria Acosta, Ulerio, Grace, Chanana, Anita M., Mackay-Wiggan, Julian M., Bickers, David R., Epstein, Ervin H
Publicado em 2014

Inhibiting the Hedgehog Pathway in Patients with the Basal-Cell Nevus Syndrome

Por Tang, Jean Y., Mackay-Wiggan, Julian M., Aszterbaum, Michelle, Yauch, Robert L., Lindgren, Joselyn, Chang, Kris, Coppola, Carol, Chanana, Anita M., Marji, Jackleen, Bickers, David R., Epstein, Ervin H.
Publicado no N Engl J Med (2012)

Tazarotene: Randomized, Double-Blind, Vehicle-Controlled and Open-Label Concurrent Trials for Basal Cell Carcinoma Prevention and Therapy in Patients with Basal Cell Nevus Syndrome

Por Tang, Jean Y., Chiou, Albert S., Mackay-Wiggan, Julian M., Aszterbaum, Michelle, Chanana, Anita M., Lee, Wayne, Lindgren, Joselyn A., Raphael, Maria Acosta, Thompson, Bobbye J., Bickers, David R., Epstein, Ervin H.
Publicado no Cancer Prev Res (Phila) (2014)